Lubzina, Poland

Zbigniew Majka

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Zbigniew Majka: Innovator in Pharmaceutical Chemistry

Introduction

Zbigniew Majka is a notable inventor based in Lubzina, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on 3-phenylpropionic acid derivatives. With a total of five patents to his name, Majka's inventions are paving the way for advancements in medical treatments.

Latest Patents

Majka's latest patents focus on 3-phenylpropionic acid derivatives, which are new compounds that serve as ligands for the PPAR-gamma receptor. These compounds are crucial for developing medicaments aimed at treating diseases mediated by this receptor. The first patent describes the compounds' structural formula, detailing various substituents and their therapeutic applications. The second patent outlines a method for treating or preventing conditions related to the PPAR-gamma receptor by administering these compounds in effective amounts.

Career Highlights

Throughout his career, Zbigniew Majka has worked with reputable companies such as Adamed Sp. z o.o. and Adamed Pharma S.A. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Majka has collaborated with several professionals in his field, including Katarzyna Ewa Rusin and Krzysztof Kurowski. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Zbigniew Majka is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His contributions through patents and collaborations highlight his commitment to innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…